Newsletter Tool

To view this email as a web page, click here

Today's Rundown

Moderna scores FDA authorization for its COVID-19 vaccine, adding key 2nd shot as nationwide campaign ramps up
Congressional leaders include surprise billing fix, more provider relief money in COVID-19 package
IBM links with Salesforce to offer digital COVID-19 vaccine passports
Beckman Coulter plans $4, high-volume COVID-19 antigen test
Codagenix, Serum Institute take nasal COVID-19 vaccine into clinic
WuXi lays out €150M to take over Bayer plant in Germany, boosting pandemic supply network
COVID-19 tracker: Codagenix, Serum Institute launch intranasal vaccine study; Salesforce taps IBM's health pass to help businesses reopen

Featured Story

Moderna scores FDA authorization for its COVID-19 vaccine, adding key 2nd shot as nationwide campaign ramps up

By Eric Sagonowsky

When COVID-19 began spreading earlier this year, the prospect of coronavirus vaccines launching before year’s end seemed like the longest of long shots. Now, partly in thanks to the research partnership between the federal government and industry, the U.S. has its second authorized COVID-19 vaccine. scores FDA nod for its COVID shot, adding key 2nd option

Congressional leaders include surprise billing fix, more provider relief money in COVID-19 package

By Robert King

Congressional leaders made an agreement for a new $900 billion COVID-19 relief package that includes a provider-friendly end to surprise medical bills.

IBM links with Salesforce to offer digital COVID-19 vaccine passports

By Conor Hale

In the final act of the 2011 film "Contagion," people wore bar-coded wristbands to prove they had been inoculated against the deadly, pandemic virus. But in 2021, of course, the vaccinated will be able to use a blockchain-powered smartphone app, according to IBM and Salesforce.

Beckman Coulter plans $4, high-volume COVID-19 antigen test

By Conor Hale

Beckman Coulter plans to launch a $4 coronavirus antigen test designed for mass screening, with the goal of shipping up to 25 million per month by March.

Codagenix, Serum Institute take nasal COVID-19 vaccine into clinic

By Nick Paul Taylor

Codagenix and the Serum Institute of India have begun a first-in-human clinical trial of their single-dose intranasal COVID-19 vaccine. The partners are assessing the live attenuated candidate, COVI-VAC, in a 48-subject phase 1 clinical trial in the U.K.

WuXi lays out €150M to take over Bayer plant in Germany, boosting pandemic supply network

By Fraiser Kansteiner

Shanghai's WuXi Biologics is stumping up €150 million ($183.3 million) to take over Bayer's drug substance manufacturing facility in Wuppertal, Germany. Pending regulatory approval, the deal is expected to close in 2021's first half, with the site expected to kick off drug substance and product manufacturing sometime next year, the companies said.

COVID-19 tracker: Codagenix, Serum Institute launch intranasal vaccine study; Salesforce taps IBM's health pass to help businesses reopen

By Eric Sagonowsky,Angus Liu,Kyle Blankenship,Conor Hale,Fraiser Kansteiner

Codagenix and the Serum Institute of India started a human study of their single-dose intranasal vaccine hopeful. IBM will use its Digital Health Pass to help Salesforce ease business reopenings. Beckman Coulter is plotting the launch of a $4 antigen test. Plus, Walgreens and CVS kicked off vaccination efforts in long-term care facilities.

COVID-19 Tracker